You can buy or sell PHIO and other stocks, options, and ETFs commission-free!
Phio Pharmaceuticals Corp. Common Stock, also called Phio Pharmaceutical, is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA. The listed name for PHIO is Phio Pharmaceuticals Corp. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 25, After Hours